Ariad Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares in the offering are to be sold by ARIAD.